The contribution of immunogenetics to the development of aPL and APS has been addressed mainly by family studies and by population studies looking at the HLA region, but recent data highlighted the role of variations affecting non-MHC genes in APS susceptibility [11,19,20]. The gene discussed is HLA-C; the disease is autoimmune polyendocrinopathy.